Global Next Generation Sequencing Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Next Generation Sequencing market size will reach US$ 4983 million by 2031.
Next-Generation Sequencing (NGS) refers to a group of advanced DNA and RNA sequencing technologies that allow for massively parallel sequencing of millions to billions of nucleic acid fragments in a single run. Unlike traditional Sanger sequencing, which processes one DNA fragment at a time, NGS platforms can simultaneously sequence large volumes of genetic material, making the process significantly faster, more scalable, and cost-effective. NGS technologies include short-read sequencing, long-read sequencing, and single-molecule real-time sequencing. These platforms are capable of decoding entire genomes, transcriptomes, or targeted regions with high sensitivity and resolution. NGS has revolutionized genomics by enabling applications in clinical diagnostics (e.g., cancer gene panels, hereditary disease testing), biomedical research, infectious disease monitoring, agriculture, and environmental studies. Its integration with bioinformatics tools allows for precise mutation detection, gene expression profiling, epigenomic mapping, and microbiome analysis.
The global Next-Generation Sequencing (NGS) market is experiencing rapid growth, driven by increasing demand for high-throughput, cost-effective genomic analysis in clinical diagnostics, biomedical research, and agricultural genomics. Expanding applications—such as cancer genomics, non-invasive prenatal testing (NIPT), infectious disease surveillance, personalized medicine, and microbiome studies—are fueling market adoption. In parallel, technological innovations including lower-cost benchtop sequencers, AI-powered bioinformatics platforms, and integrated end-to-end workflows are making NGS more accessible to smaller labs and emerging economies. North America currently holds the largest market share due to early adoption, infrastructure, and funding, while Asia-Pacific is expected to be the fastest-growing region, driven by increased government investment in precision medicine and genomic research. However, challenges remain in data interpretation, regulatory compliance, and reimbursement policies, which could impact the pace of adoption. Overall, the NGS market is poised for strong, sustained growth, underpinned by its transformative potential in healthcare, agriculture, and environmental science.
LPI (LP Information)' newest research report, the “Next Generation Sequencing Industry Forecast” looks at past sales and reviews total world Next Generation Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Next Generation Sequencing sales for 2025 through 2031. With Next Generation Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next Generation Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Next Generation Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Next Generation Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next Generation Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next Generation Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next Generation Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of Next Generation Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Whole Genome Sequencing
Whole Exome Sequencin
Targeted Sequencing
RNA Sequencing
Others
Segmentation by Application:
Basic Life Science Research
Medical and Disease Research
Clinical Diagnostics and Precision Medicine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Agilent Technologies
Roche
QIAGEN
PacBio
Oxford Nanopore Technologies
Element Biosciences
PerkinElmer
Bio‑Rad
Eurofins
PierianDx
Integrated DNA Technologies
GATC biotech AG
Macrogen
BGI
Please note: The report will take approximately 2 business days to prepare and deliver.
Next-Generation Sequencing (NGS) refers to a group of advanced DNA and RNA sequencing technologies that allow for massively parallel sequencing of millions to billions of nucleic acid fragments in a single run. Unlike traditional Sanger sequencing, which processes one DNA fragment at a time, NGS platforms can simultaneously sequence large volumes of genetic material, making the process significantly faster, more scalable, and cost-effective. NGS technologies include short-read sequencing, long-read sequencing, and single-molecule real-time sequencing. These platforms are capable of decoding entire genomes, transcriptomes, or targeted regions with high sensitivity and resolution. NGS has revolutionized genomics by enabling applications in clinical diagnostics (e.g., cancer gene panels, hereditary disease testing), biomedical research, infectious disease monitoring, agriculture, and environmental studies. Its integration with bioinformatics tools allows for precise mutation detection, gene expression profiling, epigenomic mapping, and microbiome analysis.
The global Next-Generation Sequencing (NGS) market is experiencing rapid growth, driven by increasing demand for high-throughput, cost-effective genomic analysis in clinical diagnostics, biomedical research, and agricultural genomics. Expanding applications—such as cancer genomics, non-invasive prenatal testing (NIPT), infectious disease surveillance, personalized medicine, and microbiome studies—are fueling market adoption. In parallel, technological innovations including lower-cost benchtop sequencers, AI-powered bioinformatics platforms, and integrated end-to-end workflows are making NGS more accessible to smaller labs and emerging economies. North America currently holds the largest market share due to early adoption, infrastructure, and funding, while Asia-Pacific is expected to be the fastest-growing region, driven by increased government investment in precision medicine and genomic research. However, challenges remain in data interpretation, regulatory compliance, and reimbursement policies, which could impact the pace of adoption. Overall, the NGS market is poised for strong, sustained growth, underpinned by its transformative potential in healthcare, agriculture, and environmental science.
LPI (LP Information)' newest research report, the “Next Generation Sequencing Industry Forecast” looks at past sales and reviews total world Next Generation Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Next Generation Sequencing sales for 2025 through 2031. With Next Generation Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Next Generation Sequencing industry.
This Insight Report provides a comprehensive analysis of the global Next Generation Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Next Generation Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Next Generation Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Next Generation Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Next Generation Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of Next Generation Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Whole Genome Sequencing
Whole Exome Sequencin
Targeted Sequencing
RNA Sequencing
Others
Segmentation by Application:
Basic Life Science Research
Medical and Disease Research
Clinical Diagnostics and Precision Medicine
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Agilent Technologies
Roche
QIAGEN
PacBio
Oxford Nanopore Technologies
Element Biosciences
PerkinElmer
Bio‑Rad
Eurofins
PierianDx
Integrated DNA Technologies
GATC biotech AG
Macrogen
BGI
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
134 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Next Generation Sequencing Market Size by Player
- 4 Next Generation Sequencing by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Next Generation Sequencing Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
